SavedAdd your journal

Journals / Turkish Journal of Medical Sciences / 2015 / Cilt: 45 - Sayı: 3

Correlation between antibiotic resistance and virulence ofPseudomonas aeruginosa clinical isolates

FATMA IBRAHIM SONBOL
MAHA ABD EL FATTAH KHALIL
ABDELFATTAH BADR MOHAMED
SAMEH SAMIR ALI
Pages
568–577
Publication Date
2015-08-13
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: The statistical analysis revealed a significantly positive correlation (r = 0.779, P = 0.002) between virulence factors and antimicrobial resistance marker profiles of the tested MDRPA isolates.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Background/aim: Virulent Pseudomonas aeruginosa is frequently life-threatening and often challenging to treat, and the emergence of multidrug-resistant isolates presents a critical problem for patients.
📊
Key Findings & Data:Materials and methods: Out of 44 MDRPA isolates, 12 isolates representing different resistance profiles and sources of samples were selected for further molecular studies.
💡
Conclusion & Impact:Conclusion: The statistical analysis revealed a significantly positive correlation (r = 0.779, P = 0.002) between virulence factors and antimicrobial resistance marker profiles of the tested MDRPA isolates.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Multidrug-resistant Pseudomonas aeruginosa · antibiotic · virulence factors

Abstract

Background/aim: Virulent Pseudomonas aeruginosa is frequently life-threatening and often challenging to treat, and the emergence of multidrug-resistant isolates presents a critical problem for patients. The aim of the study was concerned with molecular analysis of the virulence factors and antimicrobial resistance profile of multidrug-resistant P. aeruginosa (MDRPA). Materials and methods: Out of 44 MDRPA isolates, 12 isolates representing different resistance profiles and sources of samples were selected for further molecular studies. Polymerase chain reaction (PCR) approaches were applied to identify the genes implicated in antimicrobial resistance or virulence factors in the selected MDRPA isolates. Results: Multidrug-resistance (pstS), ß-lactamase (IMP7, IMP10, IMP13, and IMP25), and extended spectrum ß-lactamase (blaOXA50) genes were detected in all of the selected MDRPA isolates. However, only 4 (33%) MDRPA isolates were positive for the presence of the extended spectrum ß-lactamase (blaOXA2) gene. Furthermore, the hemolytic phospholipase C precursor gene (plcH) was detected in all PCR products of the tested MDRPA isolates while the exotoxin A (toxA) gene was absent. Other virulence genes were detected with variable percentage in tested isolates. Conclusion: The statistical analysis revealed a significantly positive correlation (r = 0.779, P = 0.002) between virulence factors and antimicrobial resistance marker profiles of the tested MDRPA isolates.

Özet

Background/aim: Virulent Pseudomonas aeruginosa is frequently life-threatening and often challenging to treat, and the emergence of multidrug-resistant isolates presents a critical problem for patients. The aim of the study was concerned with molecular analysis of the virulence factors and antimicrobial resistance profile of multidrug-resistant P. aeruginosa (MDRPA). Materials and methods: Out of 44 MDRPA isolates, 12 isolates representing different resistance profiles and sources of samples were selected for further molecular studies. Polymerase chain reaction (PCR) approaches were applied to identify the genes implicated in antimicrobial resistance or virulence factors in the selected MDRPA isolates. Results: Multidrug-resistance (pstS), ß-lactamase (IMP7, IMP10, IMP13, and IMP25), and extended spectrum ß-lactamase (blaOXA50) genes were detected in all of the selected MDRPA isolates. However, only 4 (33%) MDRPA isolates were positive for the presence of the extended spectrum ß-lactamase (blaOXA2) gene. Furthermore, the hemolytic phospholipase C precursor gene (plcH) was detected in all PCR products of the tested MDRPA isolates while the exotoxin A (toxA) gene was absent. Other virulence genes were detected with variable percentage in tested isolates. Conclusion: The statistical analysis revealed a significantly positive correlation (r = 0.779, P = 0.002) between virulence factors and antimicrobial resistance marker profiles of the tested MDRPA isolates.

🔖

Cite This Article

SONBOL, F. I., KHALIL, M. A. E. F., MOHAMED, A. B., ALI, S. S. (2015). Correlation between antibiotic resistance and virulence ofPseudomonas aeruginosa clinical isolates. Turkish Journal of Medical Sciences, Cilt: 45 - Sayı: 3, 568–577. https://ajindex.com/articles/113924

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (9)

  1. Obritsch MD, Fish DN, MacLaren R, Jung R. Nosocomial infections due to multidrug-resistant Pseudomonas aeruginosa: epidemiology and treatment options. Pharmacotherapy 2005; 10: 1353–1364. 2. Story RM, Weber IT, Steitz TA. The structure of the E. coli recA protein monomer and polymer. Nature 1992; 355: 318–325. 3. Shanooba MP, Vishnu JG, Nitin VG, Sandip SP. Antibacterial targets in Pseudomonas aeruginosa. Int J Pharma Appl 2011; 2159–2164. 4. Zourob M, Elwary S, Turner A, editors. Principles of Bacterial Detection: Biosensors, Recognition Receptors and Rossolini GM, Mantengoli E. Treatment and control of severe infections caused by multiresistant Pseudomonas aeruginosa. Clin Microbiol Infect 2005; 11: 17–32.
  2. Sambrook J, Fritsch EF, Maniatis T. Molecular Cloning. A Laboratory Manual. Cold Spring Harbor, NY, USA: Cold Spring Harbor Laboratory Press; 1989. Crăciunaş C, Butiuc-Keul A, Flonta M, Brad A, Sigarteu M. Application of molecular techniques to the study of Pseudomonas aeruginosa clinical isolate in Cluj-Napoca, Romania. Analele Universităţii din Oradea-Fascicula Biologie 2010; XVII: 243–247.
  3. Lanotte P, Watt S, Mereghetti L, Dartiguelongue N, Rastegar- Lari A, Quentin R. Genetic features of Pseudomonas aeruginosa isolates from cystic fibrosis patients compared with those isolates from other origins. J Med Microbiol 2004; 53: 73–81.
  4. Strateva T, Petrova G, Perenovsk P, Mitov I. Bulgarian cystic fibrosis Pseudomonas aeruginosa isolates: antimicrobial susceptibility and neuraminidase-encoding gene distribution. J Med Microbiol 2009; 58: 690–692.
  5. Stover CK, Pham XQ, Erwin AL, Mizoguchi SD, Warrener P, Hickey MJ, Brinkman FSL, Hufnagle WO, Kowalik DJ, Lagrou M et al. Complete genome sequence of Pseudomonas aeruginosa PAO1, an opportunistic pathogen. Nature 2000; 406: 959–964.
  6. Yah SC, Eghafona NO, Enabulele IO. Prevalence of plasmids mediated Pseudomonas aeruginosa resistant genes from burn wound patients at the University of Benin Teaching Hospital Benin City, Nigeria J Biomed Sci 2006; 5: 61–68.
  7. Daini OA, Onyeaghala CG. Plasmid-mediated aminoglycoside resistance of clinical isolates of Pseudomonas aeruginosa. Global Advanced Research Journal of Microbiology 2012; 1: 52–56.
  8. Livermore DM, Williams JD. β-Lactams: mode of action and mechanisms of bacterial resistance. In: Lorian V, editor. Antibiotics in Laboratory Medicine. 4th ed. Baltimore, MD, USA: Williams and Wilkins; 1996. pp. 502–578.
  9. Ambler RP, Coulson AF, Frere JM, Joris B, Waley SG. A standard number